排序方式: 共有13条查询结果,搜索用时 46 毫秒
1.
G. Senna M. Guerriero P. L. Paggiaro F. Blasi M. Caminati E. Heffler M. Latorre G. W. Canonica on Behalf of SANI 《Clinical and molecular allergy : CMA》2017,15(1):9
Even if severe asthma (SA) accounts for 5–10% of all cases of the disease, it is currently a crucial unmet need, owing its difficult clinical management and its high social costs. For this reason several networks, focused on SA have been organized in some countries, in order to select these patients, to recognize their clinical features, to evaluate their adherence, to classify their biological/clinical phenotypes, to identify their eligibility to the new biologic therapies and to quantify the costs of the disease. Aim of the present paper is to describe the ongoing Italian Severe Asthma Network (SANI). Up today 49 centres have been selected, widespread on the national territory. Sharing the same diagnostic protocol, data regarding patients with SA will be collected and processed in a web platform. After their recruitment, SA patients will be followed in the long term in order to investigate the natural history of the disease. Besides clinical data, the cost/benefit evaluation of the new biologics will be verified as well as the search of peculiar biomarker(s) of the disease. 相似文献
2.
3.
KHATIJAH HAJI HUSSIN ZAHARINA MOHAMAT SANI 《Botanical journal of the Linnean Society. Linnean Society of London》1998,127(2):159-174
A comparative study was undertaken on the leaves of 12 Sterculia species in order to assess anatomical variations which may be useful in species identification and to evaluate their significance in the taxonomy of the genus. All species have glandular and non-glandular trichomes, anomocytic stomata, multiple and mucilaginous epidermis, mucilaginous cavities and druses in mesophyll tissues. A small amount of variation was observed in the outline of transverse sections of midribs and petioles, the presence of central vascular bundles, and the type of trichomes. Some characters, such as the vertically divided adaxial epidermis in S. macrophylla , are unique to certain species and are therefore useful in diagnostic characters, while S. coccinea and S. elongata appear to be similar in the structure of the petiole and midrib. The results, however, do not show any groupings of species and do not support the observations of others on groups derived from wood anatomy. 相似文献
4.
5.
6.
RYO Hanajiri GELINA M. SANI PATRICK J. HANLEY CASSIA G. SILVEIRA ESPER G. KALLAS MICHAEL D. KELLER CATHERINE M. BOLLARD 《Cytotherapy》2019,21(8):840-855
BackgroundZika virus (ZIKV) infection can cause severe birth defects in newborns with no effective currently available treatment. Adoptive transfer of virus-specific T cells has proven to be safe and effective for the prevention or treatment of many viral infections, and could represent a novel treatment approach for patients with ZIKV infection. However, extending this strategy to the ZIKV setting has been hampered by limited data on immunogenic T-cell antigens within ZIKV. Hence, we have generated ZIKV-specific T cells and characterized the cellular immune responses against ZIKV antigens.MethodsT-cell products were generated from peripheral blood of ZIKV-exposed donors, ZIKV-naive adult donors and umbilical cord blood by stimulation with pentadecamer (15mer) overlapping peptide libraries spanning four ZIKV polyproteins (C, M, E and NS1) using a Good Manufacturing Practice–compliant protocol.ResultsWe successfully generated T cells targeting ZIKV antigens with clinically relevant numbers. The ex vivo–expanded T cells comprised both CD4+ and CD8+ T cells that were able to produce Th1-polarized effector cytokines and kill ZIKV-infected HLA-matched monocytes, confirming functionality of this unique T-cell product as a potential “off-the-shelf” therapeutic. Epitope mapping using peptide arrays identified several novel HLA class I and class II–restricted epitopes within NS1 antigen, which is essential for viral replication and immune evasion.DiscussionOur findings demonstrate that it is feasible to generate potent ZIKV-specific T cells from a variety of cell sources including virus naïve donors for future clinical use in an “off-the-shelf” setting. 相似文献
7.
8.
9.
10.